Skip to main content
SpringerLink
Log in

Serum testosterone to trigger re-dosing of goserelin improves QOL

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Serum testosterone to trigger re-dosing of goserelin improves QOL. Pharmacoecon. Outcomes News 398, 14 (2003). https://doi.org/10.1007/BF03275814

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03275814

Keywords

Search

Navigation